Related Experiment Videos
Analgesia in the acute abdomen
Annals of the Royal College of Surgeons of England
|July 1, 1986
Summary
Sublingual buprenorphine did not provide superior pain relief for acute abdominal pain compared to placebo. This study suggests buprenorphine can be used without masking crucial diagnostic signs.
Area of Science:
- Emergency Medicine
- Pharmacology
- Clinical Trials
Background:
- Acute abdominal pain is a common presentation in emergency settings.
- Effective pain management is crucial while avoiding diagnostic masking.
Purpose of the Study:
- To evaluate the efficacy of sublingual buprenorphine in managing acute abdominal pain.
- To determine if buprenorphine alters physical signs, potentially masking diagnoses.
Main Methods:
- Prospective, sequential, double-blind trial.
- 288 patients with acute abdominal pain were randomized.
- Treatment groups received sublingual buprenorphine (200 mcg or 400 mcg) or placebo.
Main Results:
- Pain relief was dose-dependent but showed no significant difference between buprenorphine and placebo.
- Physical signs changed with dosage but did not impede clinical diagnosis.
Conclusions:
- Sublingual buprenorphine is not more effective than placebo for acute abdominal pain.
- Buprenorphine can be safely administered without compromising diagnostic accuracy in acute abdominal pain cases.